About TPD 2018
As the drug discovery opportunity hidden within the proteome opens up and gains tremendous investment, the inaugural Targeted Protein Degradation Summit 2018 was a first of its kind and a sold out event in terms of a dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to capitalize on this emerging therapeutic class of drugs.
What did you miss in 2018?
Get your copy of the 2018 Post Event Report for a lowdown on;
- Who attended by industry and seniority
- Top session and interview highlights
- How you can get involved at TPD 2019
“Great experience. Very professionally managed from speaks and topics to networking opportunities and food preparation”
Jason Burke, Senior Scientist, AbbVie
“For an inaugural meeting, this ticked the boxes and then some. Great insight from the founders and the main players in the field and a great deal of enthusiasm in the room for the ongoing research and the future of TPD”
Ian Hickson, Prof. Drug Discovery Cancer Bioscience, Newcastle University